Moxifloxacin, 400mg/250ml solution for infusions

Sector: Pharmaceuticals
Price: Contract Price
Packaging: 250 ml polyethylene bottles Bottlepack in package No. 12, No.28. 250 ml glass bottles
Terms of Delivery: FCA (Incoterms 2010)
Full Product Information:
Moxifloxacin inhibits topoisomerase II (DNA gyrase) and topoisomerase IV - enzymes necessary for replication, transcription, repair and recombination of bacterial DNA. Moxifloxacin is indicated to treat: - community-acquired pneumonia; - complicated skin and soft tissue infections; Moxifloxacin should only be used when it is considered unpractical to use the antibacterials usually recommended to treat these infections at initial stage. It is necessary to consider the official recommendations on appropriate use of antibacterials.

Another products from the category "Pharmaceuticals"

Belarus
Hamoven is an original medicinal product, solution for infusions belonging to blood substitutes and protein fraction of blood plasma.
Belarus
Reogemin is polyionic solution for infusion which belongs to a group of plasma substituting and perfusion solutions.
Belarus
Plasma substituting and perfusion solutions. Electrolyte solution. 9 mg/ml isotonic infusion solution of sodium chloride is colourless transparent liquid. The solution is produced sterile and non-pyro...